SCHEMBL28560623

SCHEMBL28560623

Cc1cc(OC(=O)N2CCN(C(=O)CCc3ccccc3N)CC2)n(-c2ccccc2)n1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ MAPT P10636 4/20 0.40
▸ HPGD P15428 1/20 0.40
▸ ALOX5 P09917 2/20 0.39
▸ KMT2A Q03164 5/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ CYP1A2 P05177 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ GAA P10253 2/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ PTGS1 P23219 1/20 0.38
▸ P2RY12 Q9H244 1/20 0.37
▸ NTRK1 P04629 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21845297 0.83 GAA (0.43) L3MBTL1MAPTHPGDKMT2ACYP1A2
Hydrochloric Acid SCHEMBL21808300 0.82 GAA (0.42) L3MBTL1MAPTHPGDKMT2ACYP1A2
SCHEMBL21808533 0.79 HRH3 (0.48) MAPTKMT2ACYP1A2MAPK1CYP2C19
SCHEMBL23668147 0.79 NTRK1 (0.46) MAPTKMT2ACYP1A2MAPK1CYP2C19
Hydrochloric Acid SCHEMBL21808492 0.78 HRH3 (0.47) MAPTKMT2ACYP1A2MAPK1CYP2C19
SCHEMBL23680073 0.77 GAA (0.42) L3MBTL1MAPTHPGDKMT2ACYP1A2
SCHEMBL23668124 0.77 TSHR (0.52) MAPTKMT2AMEN1CYP1A2MAPK1
SCHEMBL23668130 0.76 P2RY12 (0.43) KMT2ACYP1A2MAPK1CYP2C19GAA
SCHEMBL21808515 0.76 P2RY12 (0.43) KMT2ACYP1A2MAPK1CYP2C19GAA
SCHEMBL23668144 0.76 P2RY12 (0.43) KMT2AGAAALDH1A1P2RY12NTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112714760-A Edaravone prodrug compound and medical application thereof in treating or improving neurodegenerative or motor neuron diseases J2H生物科技有限公司 2021-04-27 — — CN disclosed
Send feedback